A validated rating scale for hyperkinetic facial lines

Archives of Facial Plastic Surgery

Volumn 6, Issue 4, 2004, Pages 253-256

  Kim, Eugene J ^a   Reeck, Jay B ^a   Maas, Corey S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CUTANEOUS PARAMETERS; FACE; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY; VALIDATION STUDY;

ADULT; FACE; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SKIN AGING;

EID: 4944267423     PISSN: 15212491     EISSN: 15383660     Source Type: Journal    
DOI: 10.1001/archfaci.6.4.253     Document Type: Article

References (19)

1. Kligman AM, Zheng P, Lavker RM. The anatomy and pathogenesis of wrinkles. Br J Dermatol. 1985;113:37-42. (Pubitemid 15006909)
2. Maas CS, Denton AB. Synthetic soft tissue substitutes: 2001. Facial Plast Surg Clin North Am. 2001;9:219-227.
3. Monheit GD, Chastain MA. Chemical peels. Facial Plast Surg Clin North Am. 2001; 9:239-255.
4. Roberts TL III, Ellis LB. In pursuit of optimal rejuvenation of the forehead: endoscopic brow lift with simultaneous carbon dioxide laser resurfacing. Plast Reconstr Surg. 1998;101:1075-1084. (Pubitemid 28162843)
5. Zimbler MS, Holds JB, Kokoska MS, et al. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial. Arch Facial Plast Surg. 2001;3:165-169.
6. Daniell HW. Smoker's wrinkles: a study in the epidemiology of "crow's feet". Ann Intern Med. 1971;75:873-880.
7. Lowe NJ, Maxwell A, Harper H. Botulinum A exotoxin for glabellar folds: a doubleblind, placebo-controlled study with an electromyographic injection technique. J Am Acad Dermatol. 1996;35:569-572. (Pubitemid 26427059)
8. Blitzer A, Brin MF, Keen MS, Aviv JE. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg. 1993;119: 1018-1022. (Pubitemid 23270408)
9. Foster JA, Barnhorst D, Papay F, Oh PM, Wulc AE. The use of botulinum A toxin to ameliorate facial kinetic frown lines. Ophthalmology. 1996;103:618-622. (Pubitemid 26114232)
10. Bikhazi NB, Maas CS. Refinement in the rehabilitation of the paralyzed face using botulinum toxin. Otolaryngol Head Neck Surg. 1997;117:303-307. (Pubitemid 27441456)
11. Blitzer A, Binder WJ, Aviv JE, Keen MS, Brin MF. The management of hyperfunctional facial lines with botulinum toxin: a collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg. 1997;123:389-392. (Pubitemid 27180937)
12. Ahn KY, Park MY, Park DH, Han DG. Botulinum toxin A for the treatment of facial hyperkinetic wrinkle lines in Koreans. Plast Reconstr Surg. 2000;105: 778-784.
13. Keen, M, Blitzer A, Aviv J. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study. Plast Reconstr Surg. 1994; 94:94-99. (Pubitemid 24243399)
14. Ahn MS, Catten M, Maas CS. Temporal brow lift using botulinum toxin A. Plast Reconstr Surg. 2000;105:1129-1135; discussion 1136-1139. (Pubitemid 30158825)
15. Heckmann M, Schon-Hupka G. Quantification of the efficacy of botulinum toxin type A by digital image analysis. J Am Acad Dermatol. 2001;45:508-514. (Pubitemid 32917243)
16. Grove GL, Grove MJ, Leyden JJ. Optical profilometry: an objective method for quantification of facial wrinkles. J Am Acad Dermatol. 1989;21:631-637. (Pubitemid 19211187)
17. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174. (Pubitemid 8054849)
18. Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics. 1977; 33:363-374. (Pubitemid 8131514)
19. Ramirez AL, Reeck J, Maas CS. Botulinum toxin type B (Myobloc) in the management of hyperkinetic facial lines. Otolaryngol Head Neck Surg. 2002;126: 459-467. (Pubitemid 41123531)